An article titled “Pulmonary arterial hypertension redefined” published June 9, 2016, misstated the authors’ financial disclosures. Funding was provided by educational grants from Bayer and United Therapeutics Corporation. All but two coauthors had no disclosures; the remaining authors disclosed numerous ties to industry sources.
